95 related articles for article (PubMed ID: 29260512)
1. [Construction and Evaluation of a Novel TB Vaccine Candidate Based on
Huang JL; Liu SJ; Su L; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):814-818. PubMed ID: 29260512
[TBL] [Abstract][Full Text] [Related]
2. Construction of two Listeria ivanovii attenuated strains expressing Mycobacterium tuberculosis antigens for TB vaccine purposes.
Lin Q; Zhou M; Xu Z; Khanniche A; Shen H; Wang C
J Biotechnol; 2015 Feb; 196-197():20-6. PubMed ID: 25612873
[TBL] [Abstract][Full Text] [Related]
3. [Genetic Recombiniation and Protein Expression Detection of
Ren CY; Liu SJ; Pu QK; Jiang MJ; Zhou MY; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):819-824. PubMed ID: 28598105
[TBL] [Abstract][Full Text] [Related]
4. [Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant
Liu T; Liu SJ; Zhou YZ; Zhang YW; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):1-6. PubMed ID: 31950781
[TBL] [Abstract][Full Text] [Related]
5. The Protein Expression Level of a Heterogeneous Gene Inserted in LIPI-1 of the Listeria ivanovii Genome Relies on Its Insertion Orientation.
Liu S; Jiang M; Su L; Tang T; Zhang X; Li Y; Pu Q; Ren C; Wang C
J Mol Microbiol Biotechnol; 2017; 27(5):269-276. PubMed ID: 29161696
[TBL] [Abstract][Full Text] [Related]
6. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
[TBL] [Abstract][Full Text] [Related]
7. Intranasal vaccination with Listeria ivanovii as vector of Mycobacterium tuberculosis antigens promotes specific lung-localized cellular and humoral immune responses.
Jiang MJ; Liu SJ; Su L; Zhang X; Li YY; Tang T; Wang C
Sci Rep; 2020 Jan; 10(1):302. PubMed ID: 31942003
[TBL] [Abstract][Full Text] [Related]
8. Attenuated Listeria monocytogenes, a Mycobacterium tuberculosis ESAT-6 antigen expression and delivery vector for inducing an immune response.
Yin Y; Tian D; Jia Y; Gao Y; Fu H; Niu Z; Sun L; Jiao X
Res Microbiol; 2012; 163(8):540-9. PubMed ID: 22835946
[TBL] [Abstract][Full Text] [Related]
9. A Listeria ivanovii balanced-lethal system may be a promising antigen carrier for vaccine construction.
Lei Y; Zhou Y; Zhang Y; Liu S; Tian S; Ou Q; Liu T; Huang H; Tang T; Wang C
Microb Biotechnol; 2022 Nov; 15(11):2831-2844. PubMed ID: 36069650
[TBL] [Abstract][Full Text] [Related]
10. [Immunobiologic characteristics of a recombinant Listeria monocytogenes expressing Mycobacterium tuberculosis antigens].
Yin Y; Zhao D; Kang M; Tan W; Lian K; Hu M; Chen X; Pan Z; Jiao X
Wei Sheng Wu Xue Bao; 2013 Dec; 53(12):1340-6. PubMed ID: 24697107
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Mycobacterium bovis double knockout mce2-phoP as candidate vaccine against bovine tuberculosis.
García E; Bianco MV; Gravisaco MJ; Rocha RV; Blanco FC; Bigi F
Tuberculosis (Edinb); 2015 Mar; 95(2):186-9. PubMed ID: 25620706
[TBL] [Abstract][Full Text] [Related]
12. A spontaneous genomic deletion in Listeria ivanovii identifies LIPI-2, a species-specific pathogenicity island encoding sphingomyelinase and numerous internalins.
Domínguez-Bernal G; Müller-Altrock S; González-Zorn B; Scortti M; Herrmann P; Monzó HJ; Lacharme L; Kreft J; Vázquez-Boland JA
Mol Microbiol; 2006 Jan; 59(2):415-32. PubMed ID: 16390439
[TBL] [Abstract][Full Text] [Related]
13. [
Ou Q; Chen Z; Tang J; Chen M; Zhang Y; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1159-1166. PubMed ID: 38162066
[TBL] [Abstract][Full Text] [Related]
14. Coating With Chitooligosaccharides Enhances the Cytokine Induction of Listeria ivanovii-Based Vaccine Strain.
Zhang X; Su L; Huang H; Jiang M; Liu S; Li Y; Liu T; Zhou Y; Tang T; Mahdy SE; Wang C
J Pharm Sci; 2019 Sep; 108(9):2926-2933. PubMed ID: 30995448
[TBL] [Abstract][Full Text] [Related]
15. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
16. Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system.
Bottai D; Frigui W; Clark S; Rayner E; Zelmer A; Andreu N; de Jonge MI; Bancroft GJ; Williams A; Brodin P; Brosch R
Vaccine; 2015 May; 33(23):2710-8. PubMed ID: 25869896
[TBL] [Abstract][Full Text] [Related]
17. [Construction and Fluorescence Analysis of the Recombinant
Zhang X; Su L; Liu SJ; Li YY; Jiang MJ; Huang H; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):809-813. PubMed ID: 29260511
[TBL] [Abstract][Full Text] [Related]
18. Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.
Arbues A; Aguilo JI; Gonzalo-Asensio J; Marinova D; Uranga S; Puentes E; Fernandez C; Parra A; Cardona PJ; Vilaplana C; Ausina V; Williams A; Clark S; Malaga W; Guilhot C; Gicquel B; Martin C
Vaccine; 2013 Oct; 31(42):4867-73. PubMed ID: 23965219
[TBL] [Abstract][Full Text] [Related]
19. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
[TBL] [Abstract][Full Text] [Related]
20. Recombinant
Liang Q; Li R; Liu S; Zhang Y; Tian S; Ou Q; Chen Z; Wang C
Front Microbiol; 2022; 13():962326. PubMed ID: 35935244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
